Is Loar Holdings LOAR stock still a good opportunity in 2026 Q4 2025 Profit Exceeds Views Generate Biomedicines GENB vs Competition GENB Latest Quarter Earnings Generate Biomedicines posts AI drug pipeline wins BETRW Better Home releases no quarterly earnings figures as leadership evaluates upcoming strategic moves First Trust Natural Gas ETF FCG Investment Case Assessment and Peer Comparison as of Q1 2026 Eli Lilly and Company LLY GLP1 Oral Market Competition Intensifies As Early Uptake Data Benchmarks Novo Nordisks Oral Wegovy Lead PAMT CORP PAMT Stock Whats Next PAMT CORP posts 105 negative EPS surprise trails estimates Is Inhibikase Therapeutics IKT stock reversing trend Inhibikase Therapeutics notches 136 EPS beat on narrower loss Linde plc LIN Secures LongTerm OnSite HyCO Supply Contract for Deepak Chem Techs Gujarat Polycarbonate Project